Genmab — Marts 2025
-
Transactions in connection with share buy-back program
Mar 31, 2025 https://ir.genmab.com/news-releases/news-release-details/transactions-connection-share-buy-back-program-48 -
GENMAB: TIVDAK OPNÅR EUROPÆISK GODKENDELSE TIL BEHANDLING AF LIVMODERHALSKRÆFT
17:21 -
TIVDAK
(tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer https://proinvestor.com/investornyt/1297443/tivdak-tisotumab-vedotin-approved-by-european-commission-for-previously-treated-recurrent-or-metastatic-cervical-cancer -
Positivt, men vel også forventet

-
Ja, godt nok voldsomme tider JKY….Men når man har prøvet Dot Com boblen, Finanskrisen og corona, så bliver man lidt hærdet
Men stadigvæk lidt ubehageligt, mens det står på
Lad os håbe der snart kommer ro på, selvom det er svært at få øje på med den gale mand i spidsen derovre. Tænker ikke lige han giver så let op, selvom der snart må komme et pres fra de rige “venner” 
-
-
“Stærke kræfter” køber op generelt
i USA nu, så MÅSKE tid til rebound…om det så holder vil tiden vise
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind